« Previous
Research in Social and Administrative Pharmacy
Volume 6, Issue 3
, Pages 257-267
, September 2010
Identifying early prescribers of Cycloxygenase-2 Inhibitors (COX-2s) in Nova Scotia, Canada: Considerations for targeted academic detailing
References
- . http://secure.cihi.ca/cihiweb/products/Drug_Expenditure_in_Canada_1985_2007_e.pdfAccessed November 10, 2008
- . Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82(4):581–629
- . Consumer choice as an evolutionary process: an operant interpretation of adopter behavior. Adv Consum Res. 1994;21:312–317
- . Consumer Behavior and Marketing Actions. 2nd ed. Boston, MA: Kent Publishing Company; 1983;443–956
- . A propositional inventory for new diffusion research. J Consum Res. 1985;11:849–869
- . Behavioral versus demographic predictors of early adoption: a critical analysis and comparative test. J Market Theor Pract. 2003;11(4):84–95
- . Does the early adopter of drugs exist? A population-based study of general practitioners' prescribing of new drugs. Eur J Clin Pharmacol. 2004;60:667–672
- . Characterizing early prescribers of newly marketed drugs in Canada: a population based study. Eur J Clin Pharmacol. 2007;63:597–604
- . Diffusion of Innovations. New York, NY: The Free Press; 1983;
- . Why physicians start or stop prescribing a drug: literature review and formulary implications. Formulary. 2002;37:186–194
- . Nova Scotia seniors' pharmacare information. 2008. www.gov.ns.ca/health/pharmacareAccessed October 20, 2008
- . Canadian Disease and Therapeutic Index. IMS Health: Kirkland, PQ; 2005;
- . Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Intern Med. 2006;36:308–319
- . COX-2 chronology. Gut. 2005;54:1509–1514
- . COX-2 inhibitors. Lancet. 1999;353:307–314
- Health Canada. Health Canada Informs Canadians of Vioxx® Withdrawal by Merck & Co., 2004; http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2004/2004_50-eng.php, Accessed October 21, 2008.
- . Systematic review: coxibs, non-steroidal anti-inflammatory drugs or no cyclooxygenase inhibitors in gastroenterological high-risk patients?. Aliment Pharmacol Ther. 2006;23:27–33
- . The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345:433–442
- . Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur J Clin Pharmacol. 2008;64:233–252
- . Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam. J Manag Care Pharm. 2006;12:265–268
- . New medicines in primary care: a review of influences on general practitioner prescribing. J Clin Pharm Ther. 2008;33:1–10
- . Influence exerted on drug prescribing by patients' attitudes and expectations and by doctors' perception of such expectations: a cohort and nested case-control study. J Eval Clin Pract. 2008;14:453–459
- . General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study. Br J Clin Pharmacol. 2005;60:526–533
- . The use of the World Health Organisation anatomical therapeutic chemical/defined daily dose methodology in Canada. Drug Inf J. 2004;38:15–27
- . An approach for the estimation of drug prescribing using the defined daily dose methodology and drug dispensation data. Theoretical considerations and practical applications. Eur J Clin Pharmacol. 2000;56:513–517
- . Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis. 1998;17:20–24
- . Reference group influence on product and brand purchase decisions. J Consum Res. 1982;9:183–194
- . Diffusion of new drugs in Danish general practice. Fam Pract. 1999;16:407–413
- . Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract. 2001;18:359–363
- . Prescribing behavior. In: Rickles NM, Wertheimer AI, Smith MC editor. Social and Behavioral Aspects of Pharmaceutical Care. 2nd ed. Sudbury, MA: Jones and Bartlett Publishers; 2009;p. 141–176
PII: S1551-7411(09)00108-9
doi: 10.1016/j.sapharm.2009.09.003
© 2010 Elsevier Inc. All rights reserved.
« Previous
Research in Social and Administrative Pharmacy
Volume 6, Issue 3
, Pages 257-267
, September 2010
